Hedge Fund Market Wizards Trading Secrets & Insights in Their Own Words (Chof360.com)
Author Jack Schwager has written the industry’s largest series of trading books by consistently getting interviews with the top traders of this generation. His book Hedge Fund Market Wizards is one of the best as it consists of interviews with professional traders with successful public track records. These asset managers are able to generate returns on capital as well as acquire and retain investment clients. Hedge Fund Market Wizards review: Jack Schwager has written six must-read trading books in his Market Wizard series. Amazingly, all of his books live up to the expectations of his readers as they provide an insight into the principles that the best traders use to make money in the market.
Friday 12/23 Insider Buying Report: COIN, HROW (Nasdaq.com)
On Tuesday, Coinbase Global’s Director, Tobias Lutke, made a $365,570 purchase of COIN, buying 10,520 shares at a cost of $34.75 a piece. Coinbase Global is trading up about 2.4% on the day Friday. Before this latest buy, Lutke bought COIN on 18 other occasions during the past year, for a total investment of $7.12M at an average of $61.46 per share. And at Harrow Health, there was insider buying on Wednesday, by Director Martin A. Makary who bought 25,000 shares at a cost of $13.37 each, for a trade totaling $334,250. Harrow Health is trading up about 3.9% on the day Friday. Makary was up about 8.3% on the purchase at the high point of today’s trading session, with HROW trading as high as $14.48 at last check today.
Insider Trading: December 26, 2022 (BIV.com)
Insider Robin Sheremeta, officer. Company: Teck Resources Ltd. (TSX:TECK). Shares owned: 8,000. Trade date: Dec. 8. Trade total: $207,500. Trade: Sale of 4,000 shares at prices from $51.75 to $52.00 to per share. Insider Michael Bruce Campbell, director. Company: Decisive Dividend Corp. (TSX-V:DE). Shares owned: 15,150. Trade date: Dec. 12. Trade total: $144,430. Trade: Sale of 28,600 shares at a price of $5.05 per share.
$7.5 Million Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying (Benzinga)
Design Therapeutics: The Trade: Design Therapeutics, Inc. (DSGN) Director Simeon George acquired a total of 900,000 shares an average price of $8.42. To acquire these shares, it cost around $7.57 million. B. Riley Financial: The Trade: B. Riley Financial, Inc. (RILY) Director Michael Joseph Sheldon bought a total of 10,026 shares at an average price of $39.86. To acquire these shares, it cost around $399.63 thousand.
Insider Buying: Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Major Shareholder Buys $5,499,995.00 in Stock (The AM Reporter)
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) major shareholder Vivo Opportunity, Llc acquired 758,620 shares of the firm’s stock in a transaction that occurred on Friday, December 23rd. The stock was purchased at an average cost of $7.25 per share, with a total value of $5,499,995.00. Following the acquisition, the insider now owns 4,340,212 shares in the company, valued at approximately $31,466,537. The acquisition was disclosed in a legal filing with the SEC.
